$0.00
$0.00 (0.00%)
End-of-day quote: 02/23/2024
OTCPK:ACUS
Acusphere Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $154.64 | $174.55 | 0.00% | 3 | $372.17B |
| MRK | Merck | NYSE | Outperform | $131.19 | $130.51 | 0.00% | 11 | $332.28B |
| ABBV | AbbVie | NYSE | Outperform | $166.42 | $178.42 | 0.00% | 11 | $293.88B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.10 | £165.99 | 0.00% | 16 | £187.73B |
| NOVN | Novartis | SWX | Hold | CHF93.37 | CHF105.00 | 0.00% | 9 | CHF190.51B |
| AMGN | Amgen | NasdaqGS | Outperform | $312.47 | $303.65 | 0.00% | 8 | $167.62B |
| SAN | Sanofi | ENXTPA | Outperform | 89.17€ | 102.80€ | 0.00% | 9 | 111.47€B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.48T |
| 4523 | Eisai | TSE | Outperform | ¥6.78k | ¥9.58k | 0.00% | 0 | ¥1.97T |
